A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's Syndrome
NCT02422407 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2018-01-19
Summary
The main objective of the study is to characterize the gene expression in immune and epithelial cells in salivary gland biopsy samples and blood of pSS (primary Sjögren's syndrome) and non-pSS participants including healthy volunteers.
Conditions
- Healthy
- Sicca Syndrome
- Sjögren's Syndrome
Interventions
- PROCEDURE
-
Biopsy
Salivary Gland
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Director · Biogen
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-03-26
- Primary Completion
- 2017-08-22
- Completion
- 2017-08-22
Countries
- United States
Study Locations
More Related Trials
-
Interstitial Lung Diseases in Primary Sjogren's Syndrome
NCT04978883 ·Status: COMPLETED
-
Efficacy of Tocilizumab in Primary Sjögren's Syndrome.
NCT01782235 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome
NCT05380804 ·Status: COMPLETED
-
Primary Sjögren Syndrome
NCT01989819 ·Status: COMPLETED
-
Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
NCT03509064 ·Status: RECRUITING
-
A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis
NCT05300932 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Oral Manifestations of Systemic Sclerosis
NCT02371005 ·Status: TERMINATED ·Phase: NA
-
Lysyl Oxidase, Semaphorin 7a and Semaphorin 3a in Patients With Systemic Sclerosis
NCT01943968 ·Status: UNKNOWN ·Phase: NA
-
Echo Systemic Sclerosis
NCT03143413 ·Status: UNKNOWN
-
Oral Health and People With Systemic Sclerosis
NCT01817361 ·Status: COMPLETED
-
Prevalence and Factors of Sarcopenia and in Patients With Primary Sjogren's Syndrome
NCT05015114 ·Status: COMPLETED
-
Implementation of a Biological Sample Collection in Systemic Sclerosis Patients
NCT04986514 ·Status: WITHDRAWN
-
AUTOANTIBODIES AND SYSTEMIC SCLEROSIS
NCT06502678 ·Status: NOT_YET_RECRUITING
-
Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis
NCT02370693 ·Status: COMPLETED ·Phase: PHASE2
-
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
NCT04904146 ·Status: RECRUITING
-
N-acetylcysteine for Primary Sjögren's Syndrome
NCT04793646 ·Status: COMPLETED ·Phase: NA
-
Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate Mofetil
NCT00853788 ·Status: COMPLETED
-
Western Sweden Systemic Sclerosis Project
NCT07345052 ·Status: RECRUITING
-
Effects of Probiotics on Gastrointestinal Symptoms and on the Immune System in Patients With Systemic Sclerosis
NCT02302352 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms
NCT05559580 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
NCT00946699 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Silicone-Associated Connective Tissue Diseases
NCT00001330 ·Status: COMPLETED
-
Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance
NCT07182981 ·Status: RECRUITING
-
Evaluation of the Serum Soluble Fractalkine as a Biomarker of Pulmonary Fibrosis in Systemic Sclerosis
NCT03508375 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis
NCT02283762 ·Status: COMPLETED ·Phase: PHASE2